Share

October 16, 2012; 79 (16) Correction

Caffeine for treatment of Parkinson disease: A randomized controlled trial

First published October 15, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31827026ef
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1717

Share

See original article:

Article Information

vol. 79 no. 16 1744
DOI: 
https://doi.org/10.1212/WNL.0b013e31827026ef
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 15, 2012.
Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    View Full Text

    Article usage

    Article usage: October 2012 to April 2022

    AbstractFullPdfSource
    Oct 20122809454Highwire
    Nov 2012099Highwire
    Dec 2012057Highwire
    Jan 2013065Highwire
    Feb 2013063Highwire
    Mar 2013023Highwire
    Apr 2013044Highwire
    May 2013053Highwire
    Jun 20131623Highwire
    Jul 20131401Highwire
    Aug 2013200Highwire
    Sep 20131152Highwire
    Oct 20131544Highwire
    Nov 2013702Highwire
    Dec 2013210Highwire
    Jan 2014303Highwire
    Feb 2014401Highwire
    Mar 2014412Highwire
    Apr 20141023Highwire
    May 20146226Highwire
    Jun 20147116Highwire
    Jul 20149114Highwire
    Aug 20140017Highwire
    Sep 20141121Highwire
    Oct 20144024Highwire
    Nov 20147116Highwire
    Dec 20146234Highwire
    Jan 20155117Highwire
    Feb 20157016Highwire
    Mar 201514024Highwire
    Apr 20155018Highwire
    May 201512134Highwire
    Jun 20159019Highwire
    Jul 20155224Highwire
    Aug 201510232Highwire
    Sep 201511114Highwire
    Oct 20153318Highwire
    Nov 20153023Highwire
    Dec 20154021Highwire
    Jan 20162028Highwire
    Feb 20160125Highwire
    Mar 2016419Highwire
    Apr 20166111Highwire
    May 20166022Highwire
    Jun 20166014Highwire
    Jul 20166018Highwire
    Aug 20169143Highwire
    Sep 201611221Highwire
    Oct 201610019Highwire
    Nov 20165019Highwire
    Dec 20166016Highwire
    Jan 20174010Highwire
    Feb 2017309Highwire
    Mar 20175112Highwire
    Apr 20171125Highwire
    May 2017607Highwire
    Jun 20175210Highwire
    Jul 20171012Highwire
    Aug 2017716Highwire
    Sep 2017567Highwire
    Oct 20171225Highwire
    Nov 20174511Highwire
    Dec 2017027Highwire
    Jan 20180921Highwire
    Feb 201801211Highwire
    Mar 20180820Highwire
    Apr 20180819Highwire
    May 20180108Highwire
    Jun 201801025Highwire
    Jul 201801126Highwire
    Aug 20180815Highwire
    Sep 201801212Highwire
    Oct 20180927Highwire
    Nov 201801332Highwire
    Dec 20180319Highwire
    Jan 201901022Highwire
    Feb 20191415Highwire
    Mar 201921019Highwire
    Apr 201901119Highwire
    May 201921616Highwire
    Jun 20190618Highwire
    Jul 20192911Highwire
    Aug 20190328Highwire
    Sep 20190528Highwire
    Oct 201922112Highwire
    Nov 20191928Highwire
    Dec 201901129Highwire
    Jan 20200618Highwire
    Feb 2020085Highwire
    Mar 20200519Highwire
    Apr 20202173Highwire
    May 20200137Highwire
    Jun 2020240Highwire
    Jul 2020080Highwire
    Aug 2020061Highwire
    Sep 20203229Highwire
    Oct 2020083Highwire
    Nov 20201127Highwire
    Dec 20201116Highwire
    Jan 20210320Highwire
    Feb 202101217Highwire
    Mar 20211818Highwire
    Apr 202111421Highwire
    May 202111433Highwire
    Jun 202101022Highwire
    Jul 202111111Highwire
    Aug 202131318Highwire
    Sep 2021174Highwire
    Oct 202101212Highwire
    Nov 202111523Highwire
    Dec 20212713Highwire
    Jan 202231527Highwire
    Feb 202212018Highwire
    Mar 20220910Highwire
    Apr 2022169Highwire

    Disputes & Debates: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Related Articles

    Alert Me